APOE and Alzheimer disease: Remarkably, all 186 cases exhibited AD hallmarks, and the percentage of APOE4 carriers was not statistically different, 12.2 and 13.1% for ≤20-year-old subjects versus ≥21-year-old subjects, respectively (Table 1).